Clinical Trial Update: Mesenchymal Stromal Cell Derivatives in the Treatment of Chronic Diabetic Foot Ulcers Type 1 and 2 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update evaluating mesenchymal stromal cell derivatives for chronic diabetic foot ulcers; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Mesenchymal stromal cell derivatives

Snippet

Sponsor: Universidad Autónoma de Bucaramanga | Conditions: Foot Ulcer, Diabetic | Phase 1, Phase 2 | Status: UNKNOWN